Diflunisal 22494-42-4

简要描述：Diflunisal 22494-42-4
Diflunisal, a salicylate derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with pharmacologic actions similar to other prototypical NSAIAs.

产品型号：abs47027316
厂商性质：生产厂家
更新时间：2025-12-05
访问量：727

产品咨询联系我们

产品分类

Product Category

生化试剂

其它生化试剂植物提取物碳水化合物生物缓冲剂荧光探针与染料表面活性剂酶&辅酶&酶底物蛋白质组学动植物激素小分子化合物生化检测试剂盒逆行示踪剂抗生素核苷&核苷酸多肽

查看全部

详细介绍

品牌	absin	CAS	22494-42-4
分子式	C13H8F2O	纯度	＞98%
分子量	250.2	货号	abs47027316
规格	25mg	供货周期	现货
主要用途	used to relieve pain accompanied with in	应用领域	化工,生物产业,农林牧渔,制药/生物制药,综合

Diflunisal 22494-42-4

产品描述
描述	Diflunisal, a salicylate derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with pharmacologic actions similar to other prototypical NSAIAs. Diflunisal possesses anti-inflammatory, analgesic and antipyretic activity. Though its mechanism of action has not been clearly established, most of its actions appear to be associated with inhibition of prostaglandin synthesis via the arachidonic acid pathway. Diflunisal is used to relieve pain accompanied with inflammation and in the symptomatic treatment of rheumatoid arthritis and osteoarthritis. .
纯度	＞98%
储存/保存方法	Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution.
基本信息
别名	二氟ni柳；二氟苯水杨酸；MK-647
外观	白色粉末
可溶性/溶解性	DMSO : 50 mg/mL (199.84 mM; Need ultrasonic) Ethanol : 20 mg/mL (79.94 mM)
生物活性
靶点	COX ,p300
In vitro(体外研究)	Diflunisal, an FDA-approved drug containing a salicylic acid substructure, inhibited CBP/p300 more potently than salicylate. Diflunisal exhibits anti-tumor activity against a specific leukemia carrying a t(8;21) translocation, a tumor previously reported to be dependent on p300 in vitro and in vivo.
In vivo(体内研究)	Diflunisal-mediated kinetic stabilization of TTR(Rate-limiting transthyretin) should ameliorate TTR amyloidoses, provided that the nonsteroidal anti-inflammatory drug liabilities can be managed clinically.
参考文献
参考文献	1. Jeske AH. J Gt Houst Dent Soc. 1999, 71(4):39-40. 2. Mao H, et al. J Am Chem Soc. 2001, 123(43):10429-35. 3. Moore PA, Hersh EV. J Am Dent Assoc. 2001, 132(4):451-6.

研究领域
研究领域	Immunology CancerTumor biomarkers CancerTumor immunology Drug DiscoverySmall Molecule DrugLead Compound Discovery

Diflunisal 22494-42-4温馨提示：本产品仅作科研实验使用，不支持临床等研究

产品咨询

上一篇：abs470273152,2,2-Tribromoethanol 75-80-9
下一篇：abs47027317Amisulpride 71675-85-9

Diflunisal 22494-42-4

留言框

产品：

您的单位：

您的姓名：

联系电话：

常用邮箱：

省份：

详细地址：

补充说明：

验证码：